To evaluate PSA levels and kinetic cutoffs to predict positive bone scans for men with non-metastatic castration-resistant prostate cancer (CRPC) from the Shared Equal Access Regional Cancer ...

Metastatic breast cancer is complex, requiring holistic care and ongoing treatment, with varying prognosis depending on ...

A key gene that fuels the molecular cascade driving prostate cancer bone metastasis progression may open avenues for targeted therapies. Laura is an Assistant Editor for The Scientist. She has a ...

First CE marked IA algorithm for automatic detection of bone lesions onCT scan The first CE-marked IA for the detection of ...

Prostate cancer frequently metastasises to the bone due to the expression of androgen receptors, which are targeted by therapies to inhibit metastasis. Melanoma can spread widely through the ...

The term metastasis encompasses specific biological ... do not support the outgrowth of solitary cells that wander in from elsewhere (bone-marrow-derived progenitor cells and immune cells being ...

No single test can diagnose metastatic breast cancer, so oncologists use a combination of blood tests, imaging scans, and ...

Zoledronic acid is a potent, new-generation bisphosphonate indicated for the treatment of documented bone metastasis in patients with solid tumors and bone lesions associated with multiple myeloma.

In a case report published in the World Journal of Oncology, an elderly female patient was diagnosed with mast cell leukemia (MCL), with imaging showing extensive osteoblastic metastatic lesions. MCL ...

[20] The maximum recommended zoledronic acid dose for the treatment of bone metastases is 4 mg by IV infusion, infused over no less than 15 minutes. Preinfusion examinations include a physical ...